Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir QD vs BID in HIV-1
NCT00358917Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2006
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir, ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Abbott Laboratories. Started Aug 2006; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00358917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358917.